Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Published on by Academic Awards

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

HASAN SARI | Cardiology | Best Researcher Award

Published on by Academic Awards

Dr. HASAN SARI | Cardiology | Best Researcher Award

Dr. HASAN SARI, Mut State Hospital, Turkey

Dr. Hasan Sarı (b. 01.12.1991, Manavgat/Antalya) is a specialist in Cardiology. With several published works in leading journals, Dr. Sarı has contributed extensively to the fields of cardiac tumors, syncope, and aortic aneurysms. Notable publications include studies on malignant fibrous histiocytoma, right atrial thrombosis, and coronary ectasia. He has also presented at international conferences, including the ACC Middle East & Eastern Mediterranean 2023 in Athens. Dr. Sarı completed an observership at the University of Minnesota Medical Center in 2023. He is actively engaged in advancing cardiology research. 📚💉❤️📈

 

Publication Profile

Orcid

Research Focus

Dr. Hasan Sarı’s research primarily focuses on cardiology with a special interest in coronary artery diseases, cardiac arrhythmias, vascular pathology, and predictive models for cardiovascular conditions. His work includes evaluating the relationship between coronary ectasia and trimethylamine N-oxide, as well as exploring CHA2DS2-VASc scores and left ventricular apical thrombosis in heart failure patients. His research contributes to advancing cardiac diagnostics, understanding heart failure, and identifying biomarkers for cardiovascular health. Dr. Sarı’s publications are crucial for clinical practice and prevention strategies in cardiology. 🫀🔬💉📊

 

Publication Top Notes 📚

  • “The Evaluation of the Relationship Between Coronary Ectasia and Trimethylamine N‐Oxide” – International Journal of Clinical Practice (2024) 📅📝
  • “Kalp Yetmezlikli Hastalarda CHA2DS2-VASc Skoru ve Sol Ventrikül Apikal Trombozu İlişkisi” – Online Türk Sağlık Bilimleri Dergisi (2022) 📅📝

Guanwei Fan | Cardiovascular research | Best Researcher Award

Published on by Academic Awards

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes  

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖